Differential Effects of Camel Milk on Insulin Receptor Signaling – Toward Understanding the Insulin-Like Properties of Camel Milk by Abdulrasheed O. Abdulrahman et al.
January 2016 | Volume 7 | Article 41
Original research
published: 27 January 2016
doi: 10.3389/fendo.2016.00004
Frontiers in Endocrinology | www.frontiersin.org
Edited by: 
Tarik Issad, 
University Paris Descartes, France
Reviewed by: 
Nicolas Boute, 
Institut de Recherche Pierre Fabre, 
France 
Kenneth Siddle, 
University of Cambridge, UK 
Milka Vrecl, 
University of Ljubljana, Slovenia
*Correspondence:
Mohammed Akli Ayoub  
Mohammed.Ayoub@tours.inra.fr
Specialty section: 
This article was submitted to 
Molecular and Structural 
Endocrinology, 
a section of the journal 
Frontiers in Endocrinology
Received: 05 October 2015
Accepted: 13 January 2016
Published: 27 January 2016
Citation: 
Abdulrahman AO, Ismael MA, 
Al-Hosaini K, Rame C, 
Al-Senaidy AM, Dupont J and 
Ayoub MA (2016) Differential Effects 
of Camel Milk on Insulin Receptor 
Signaling – Toward Understanding 
the Insulin-Like Properties of Camel 
Milk. 
Front. Endocrinol. 7:4. 
doi: 10.3389/fendo.2016.00004
Differential effects of camel Milk on 
insulin receptor signaling – Toward 
Understanding the insulin-like 
Properties of camel Milk
Abdulrasheed O. Abdulrahman1 , Mohammad A. Ismael1 , Khaled Al-Hosaini2 ,  
Christelle Rame3,4,5 , Abdulrahman M. Al-Senaidy1 , Joëlle Dupont3,4,5 and  
Mohammed Akli Ayoub1,3,4,5,6,7*
1 Biochemistry Department, College of Science, King Saud University, Riyadh, Saudi Arabia, 2 Department of Pharmacology 
and Toxicology, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia, 3 UMR7247, CNRS, Nouzilly, France, 
4 Université François-Rabelais, Tours, France, 5 L’Institut Français du Cheval et de l’Équitation, Nouzilly, France, 6 UMR85, 
Biologie et Bioinformatique des Systèmes de Signalisation Group, INRA, Unité Physiologie de la Reproduction et des 
Comportements, Nouzilly, France, 7 LE STUDIUM® Loire Valley Institute for Advanced Studies, Orléans, France
Previous studies on the Arabian camel (Camelus dromedarius) showed beneficial effects 
of its milk reported in diverse models of human diseases, including a substantial hypogly-
cemic activity. However, the cellular and molecular mechanisms involved in such effects 
remain completely unknown. In this study, we hypothesized that camel milk may act at 
the level of human insulin receptor (hIR) and its related intracellular signaling pathways. 
Therefore, we examined the effect of camel milk on the activation of hIR transiently 
expressed in human embryonic kidney 293 (HEK293) cells using bioluminescence res-
onance energy transfer (BRET) technology. BRET was used to assess, in live cells and 
real-time, the physical interaction between hIR and insulin receptor signaling proteins 
(IRS1) and the growth factor receptor-bound protein 2 (Grb2). Our data showed that 
camel milk did not promote any increase in the BRET signal between hIR and IRS1 or 
Grb2 in the absence of insulin stimulation. However, it significantly potentiated the max-
imal insulin-promoted BRET signal between hIR and Grb2 but not IRS1. Interestingly, 
camel milk appears to differentially impact the downstream signaling since it significantly 
activated ERK1/2 and potentiated the insulin-induced ERK1/2 but not Akt activation. 
These observations are to some extent consistent with the BRET data since ERK1/2 and 
Akt activation are known to reflect the engagement of Grb2 and IRS1 pathways, respec-
tively. The preliminary fractionation of camel milk suggests the peptide/protein nature of 
the active component in camel milk. Together, our study demonstrates for the first time 
an allosteric effect of camel milk on insulin receptor conformation and activation with 
differential effects on its intracellular signaling. These findings should help to shed more 
light on the hypoglycemic activity of camel milk with potential therapeutic applications.
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inTrODUcTiOn
Since many years, the camel raises passions principally due to its 
fascinating capacity of adaptation in severe environmental and 
diet conditions as well as the composition and the therapeutic 
properties of its milk (1). Indeed, many studies reported interest-
ing biochemical properties of camel milk (2–4) and its chemical 
composition (5–8), as well as the stability of its components 
compared to other mammals, such as human and bovine (2). 
Historically, camel milk was proposed as an alternative treatment 
for a number of medical problems (9) and to have potential 
benefits in many diseases, such as allergy and viral infections 
(10, 11). Nevertheless, the most important observations remains 
its hypoglycemic activity observed in type 1 diabetes using both 
human and animal models (11–18). For instance, camel milk 
was proposed as an adjunct to insulin-based therapy allowing 
the reduction of insulin doses required in patients with type 1 
diabetes (12, 14, 19). This suggests that the anti-diabetic activity 
of camel milk is mediated by an insulin-like and/or immune-
modulatory effects on beta-cells of the pancreas (17). The amino 
acid sequence of some proteins isolated from camel milk has 
been reported to be rich in half-cystine, which implies a similar-
ity with insulin family of peptides (20). The direct effect of milk 
insulin itself is also possible since camel milk has been shown 
to contain high concentrations of insulin (2, 21) compared to 
what is found in cows’ milk (16) and this seems to depend on the 
lactation stage. However, if insulin in camel milk is involved, it is 
still unclear how it can stay biologically active after its absorption 
by the intestinal epithelium even though many possibilities have 
been evoked (22). Thus, many studies reported the beneficial 
effects of camel milk in diabetes mellitus but the cellular and 
molecular mechanisms involved in such effects are completely 
unknown.
In this study, we hypothesized that camel milk may have 
a “direct” effect on insulin receptor activation and function 
at the principal target tissues. To test this hypothesis, we 
examined the effect of camel milk on the activation of human 
insulin receptor (hIR) by investigating its physical association 
with two key signaling proteins, insulin receptor signaling 
proteins (IRS1) and growth factor receptor-bound protein 2 
(Grb2), known to bind directly or indirectly to the receptor 
upon its activation/phosphorylation by insulin binding. For 
this, we used bioluminescence resonance energy transfer 
(BRET) technology as previously reported for insulin receptor 
(23, 24), epidermal growth factor receptor (EGFR) (25), and 
various G protein-coupled receptors (GPCRs) (26–28). This 
approach allowed us to assess the activation of hIR through the 
monitoring of IRS1 and Grb2 binding to the protein complex 
involving the receptor, in real-time and live cells, before and 
upon activation with insulin. Moreover, we attempted to link 
our BRET data with the hIR downstream signaling pathways by 
assessing insulin-induced phosphorylation of protein kinase B 
(or Akt) and extracellular signal-regulated kinases (or ERK1/2) 
known to translate the activation by hIR of IRS1 and Grb2, 
respectively (29, 30).
MaTerials anD MeThODs
Mammalian expression Plasmids
The mammalian expression plasmids coding for the different pro-
teins used in this study were as follow: hIR fused with Renilla lucif-
erase 8 (Rluc8) was a gift from Dr. Rasmus Jorgensen (Hagedorn 
Research Institute, Novo Nordisk, Gentofte, Denmark), the IRS1 
(1–262)-YFP was kindly obtained from Dr. Tarik Issad (Cochin 
Institute, Paris, France), and Grb2–Venus was provided by Dr. 
Kevin Pfleger (Harry Perkins Institute of Medical Research and 
Centre for Medical Research, Nedlands, Australia). All the plas-
mids were sequenced and their correct expression was verified 
by luminescence and fluorescence in parallel to BRET measure-
ments as described below.
cell culture and Transient Transfection
HEK293 cells were cultured in Gibco® Dulbecco’s modified 
Eagle’s medium (DMEM) supplemented with 10% fetal bovine 
serum (FBS), 100  units/ml penicillin, 0.1  mg/ml streptomycin, 
and maintained at 37°C in 5% CO2. For transient transfections, 
Lipofectamine® 2000 reagent was used according to the manu-
facturer’s instruction (Invitrogen, Carlsbad, CA, USA). Per well 
of 96-well microplates, the total of 200 ng of plasmids (100 ng 
of hIR–Rluc8 + 100 ng Venus/YFP-tagged proteins) and 0.5 μl 
of Lipofectamine were separately pre-incubated in 25 μl serum-
free DMEM media for 5 min at room temperature. Then both 
solutions were mixed and further incubated 20 min at room tem-
perature before adding the mix to the cells. Cells were harvested 
with 0.05% Trypsin–EDTA and after neutralization with DMEM 
cells were counted using Countess® Automated Cell Counter 
(Invitrogen, Carlsbad, CA, USA) and a density of 105 cells per 
well of 96-well plates were seeded with the transfection mix and 
incubated 48 h before BRET measurements.
camel Milk and its Fractionation
Fresh camel milk was obtained from local farms in Riyadh and 
different forms of milk have been used in this study: (i) simply 
defatted camel milk, (ii) whey versus casein fractions, (iii) milk 
protein fractions with different molecular weights, or (iv) protein 
versus non-protein fractions. Camel milk sample was defatted by 
centrifugation at 4000 rpm for 30 min at 4°C. For the separation 
of the whey components from caseins, acid precipitation at pH 
4.6 was performed by addition of 10% (v/v) acetic acid followed 
by centrifugation at 4000 rpm for 30 min at 10°C. Moreover, in 
order to separate the different protein fractions of camel milk 
according to their molecular weight, the defatted camel milk was 
subjected to centrifugation at 3500 × g and 25°C for 60 min and 
then filtration using different Amicon Ultra-15 centrifugal filters; 
10,000, 30,000, and 50,000  NMWL according to the manufac-
turer’s instructions (Millipore Corporation, Billerica, MA, USA).
gel Filtration chromatography
For this, we used Sephadex G-25 column allowing a fractiona-
tion range for globular proteins of 1000–5000 molecular weight. 
Sephadex G-25 resin (15  g) was soaked in deionized water 
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overnight at 4°C and then decanted to remove the fine particles 
that did not settle. The hydrated resin was transferred to PBS 
buffer, pH 7.4, for equilibration and packed onto a column 
(diameter, 2.6 cm; length, 40 cm; XK 26 chromatography column, 
GE Healthcare). The defatted camel milk (10 ml) was applied to 
the column and eluted with the PBS buffer. The flow rate was 
set at 1  ml/min and fractions of 3  ml were collected using a 
fast protein liquid chromatography system (AKTA purifier GE 
Healthcare, Uppsala, Sweden). The concentration of protein and 
that of peptides in the eluted fractions were monitored at 280 
and 215 nm. The amount of proteins present in the milk samples 
and fractions was quantified by the method of Bradford [100 mg 
Coomassie Brilliant Blue G-250, 50 ml 95% ethanol, 100 ml 85% 
(w/v) phosphoric acid, and 850 ml distilled water] using bovine 
serum albumin (BSA) as standard.
sodium Dodecyl sulfate-Polyacrylamide 
gel electrophoresis
Camel milk fractions were subjected to SDS-PAGE using 4% 
staking and 12% resolving polyacrylamide gels (18  mA/1  mm 
thickness gel), running 2 h in 0.5 M Tris–HCl pH 6.8 and 1.5 M 
Tris–HCl pH 8.8 buffers, respectively. Proteins were subsequently 
stained for overnight in a solution containing the mixture of 
0.1% (w/v) Coomassie blue R-250, 40% (v/v) methanol, 50% 
(v/v) water, and 10% (v/v) acetic acid. The gels were de-stained 
in a solution containing the above latter mixtures but without the 
Coomassie Blue R-250.
BreT Measurements
Forty-eight hours post-transfection, HEK293 cells initially 
cultured in 96-well white microplates to 105 cells/well were first 
pre-treated or not with 100 μl/well of defatted camel milk or its 
fractions at 37°C. After wash with PBS 1×, adherent cells were 
resuspended into 60  μl/well of PBS and BRET measurements 
were carried out in a final volume of 100 μl/well upon addition 
of 20 μl of bovine insulin (Sigma-Aldrich, St. Louis, MO, USA) 
at the indicated concentrations and 20  μl of Coelenterazine-h 
substrate (5 μM final) (Promega, Madison, WI, USA) as previ-
ously shown (25–28). BRET recordings were performed in 
real-time and live cells using Mithras2 LB 943 Multimode Reader 
(Berthold Biotechnologies, Bad Wildbad, Germany) allowing the 
sequential integration of luminescence signals detected with two 
filter settings (Rluc filter, 480 ± 20 nm; YFP filter, 540 ± 25 nm). 
For the determination of the optimal time of camel milk pre-
incubation, cells were first pre-incubated different times (0, 5, 10, 
15, 30, and 60 min) with camel milk at 37°C and BRET signals 
were then measured upon addition of 100 nM of insulin. For the 
dose–response analysis, cells were first pre-incubated 30 min at 
37°C with camel milk before BRET signals were recorded in the 
absence or presence of increasing doses of insulin (0.001, 0.1, 1, 
10, 100, 1000, 10,000 nM).
luminescence and Fluorescence
The amount of Rluc8 and YFP/Venus fusion protein 
expressed was determined for each transfection condition. 
The relative luciferase activity of hIR–Rluc8 was determined 
in parallel to BRET measurements where 80  μl of cells in 
PBS were incubated with 20 μl of Coelenterazine-h substrate 
(5  μM final) and Rluc8 emission was then measured at 
480 nm. For the fluorescence of YFP/Venus-tagged proteins, 
100 μl of cells in PBS were plated in 96-well black microplate 
and fluorescence emission was then recorded at 535 nm after 
excitation of the cells at 480  nm using the Mithras LB 943 
plate reader.
erK1/2 and akt Phosphorylation
HEK293 cells transiently co-expressing hIR–Rluc8 and Grb2–
Venus were used for ERK1/2 and Akt activation using the clas-
sical SDS-PAGE and western blotting technique as well as the 
homogenous time-resolved fluorescence (HTRF®)-based assay 
(CisBio Bioassays, Codolet, France) as previously described 
(31, 32), respectively. For SDS-PAGE and western blot, cells 
were first cultured in 6-well plate and starved overnight in 
serum-free DMEM. After pre-treatment or not with 1  ml/
well of defatted camel milk for 30 min at 37°C, cells were then 
stimulated or not with 100 nM or 1 μM of insulin in 500 μl/
well of PBS for 5 min at 37°C. Protein extraction and western 
blotting were then performed using the rabbit polyclonal 
antibody against phospho-ERK1/2 (Thr202/Tyr204) (Santa 
Cruz Biotechnology, Santa Cruz, CA, USA) diluted 1/1000. The 
western blot signals were quantified with GeneTools software 
(release 4.01.02) and expressed in arbitrary units after nor-
malization. In HTRF®-based assay, the two-plate protocol was 
used as recently described (32) after pre-treatment or not with 
defatted camel milk and stimulation or not with 100 nM insulin 
at the indicated times. The plate were then incubated for 2 h 
at room temperature before reading the fluorescence emission 
at 620 and 665 nm using the appropriate HTRF programs on 
Mithras LB 943 plate reader.
Data and statistical analysis
Data are presented in BRET ratio as previously described (33). 
For the experiments in the presence of camel milk, the effects 
are indicated as “Insulin-induced BRET” in “% of control” 
where the insulin-promoted BRET signals in cells non-treated 
with camel milk were taken as 100% of the response. The 
kinetic curves and the sigmoidal dose–response curves were 
fitted using Prism 5 graphing software (GraphPad, La Jolla, CA, 
USA) allowing the analysis according to non-linear regression 
with the following equations: BRET =  BRET0 +  (BRETmax −   
BRET0)/{1  +  10^[LogEC50  −  (insulin)]} for dose–response 
curves [BRET signals in function of Log (insulin)], and BRET =  
BRETmax*[1  −  exp(−K*time)] for kinetics [BRET signals in 
 function of time (minutes)]. The ERK1/2 and Akt data were 
represented as HTRF Ratio corresponding to the following 
ratio: (the emission at 665 nm/emission at 620 nm) × 10,000. 
One-way and two-way ANOVA analysis using Turkey’s 
multiple comparisons test was used to determine statistically 
significant differences between untreated (in the absence of 
camel milk/fractions) and treated (in the presence of camel 
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milk/fractions) conditions. ***p < 0.001, **p < 0.01, *p < 0.05; 
ns; non-significant.
resUlTs
BreT to Monitor hir activation in  
real-Time and live cells
First, we wanted to validate the applicability of BRET approach 
to investigate the activation of hIR as previously reported for 
this receptor (23, 24) as well as EGFR (25) and various GPCRs 
(26–28). This is mostly based on agonist-promoted recruitment 
of cytosolic signaling proteins to the membrane receptor reflect-
ing its activation. For this, Rluc8-tagged hIR and its interacting 
signaling proteins, IRS1 and Grb2, tagged with yellow fluorescent 
protein (IRS1–YFP) or Venus (Grb2–Venus), were used as BRET 
donor and acceptor, respectively (Figure 1A). The proteins were 
transiently and correctly expressed in HEK293 cells (data not 
shown) and BRET measurements were performed, in real-time 
and intact cells, under basal condition and upon activation with 
insulin (Figure  1A). Real-time analysis showed that stimula-
tion of cells with 100  nM of insulin significantly promoted 
BRET increase between hIR–Rluc8 and IRS1–YFP (Figure 1B) 
and Grb2–Venus (Figure  1C). This nicely occurred in time-
dependent manner with a sustained plateau even after 30 min, 
demonstrating the direct or indirect binding of the proteins to 
the activated hIR. The insulin-induced BRET increase occurred 
in a dose-dependent manner with the potency of insulin for hIR–
IRS1 (EC50 = 2.2 ± 0.6 nM, n = 6) (Figure 1D) and hIR–Grb2 
(EC50 = 4.4 ±  1.5 nM, n = 6) (Figure 1E) associations similar 
to what was previously reported (23, 29, 34), indicating insulin-
promoted hIR activation. These data clearly demonstrate the 
applicability of BRET approach to assess insulin-induced hIR 
activation in real-time and live cells.
camel Milk Potentiates insulin action on 
its receptor
In order to investigate our hypothesis regarding the putative 
effects of camel milk on insulin and its receptor signaling, 
we examined the effect of camel milk on the association of 
IRS1 and Grb2 with hIR using BRET assay. Treatment of cells 
co-expressing hIR–Rluc8 and either IRS1–YFP (Figure  2A) or 
Grb2–Venus (Figure 2B) with camel milk did not promote any 
significant BRET increase compared to untreated cells (vehicle). 
By contrast, 100 nM of insulin nicely increased the BRET signals 
in both cases as expected (Figures  2A,B). This observation 
suggests no “insulin-like” effect of camel milk on hIR–IRS1 or 
hIR–Grb2 associations in HEK293 cells. Therefore, we examined 
the effect of camel milk on insulin action by treating cells 30 min 
with camel milk before their stimulation with 100 nM of insu-
lin. Interestingly, while pre-treatment with camel milk did not 
change insulin-promoted BRET increase between hIR–Rluc8 and 
IRS1–YFP (Figure  2C), this significantly potentiated the effect 
of insulin to promote BRET increase between hIR–Rluc8 and 
Grb2–Venus (146 ± 9%, n = 10, at the plateau from 15 to 20 min 
of insulin stimulation) (Figure 2D). Such an effect was not due 
to possible artifactual effects of camel milk on the luminescence 
of hIR–Rluc8 (Figure  2E) and fluorescence of Grb2–Venus 
(Figure  2F) that might result into non-specific BRET changes. 
Of course, the BRET increase induced by insulin likely reflects the 
recruitment of the cytosolic Grb2 to the activated hIR. However, 
camel milk may induce or stabilize specific conformation of 
hIR–Rluc8 leading to stronger proximity with Grb2–Venus and/
or favorable orientation of the Rluc8 and Venus fluorophores 
following insulin stimulation without necessarily an increase in 
Grb2 binding. In all cases, camel milk-mediated potentiation sug-
gests an allosteric interaction between camel milk components 
and insulin at the level of the receptor.
Next, we performed time-course as well as dose–response 
analysis on the effect of camel milk on BRET signals. Kinetic 
analysis on BRET between hIR–Rluc8 and Grb2–Venus showed 
a time-dependent effect of camel milk with a maximal effect 
from 30  min of pre-treatment (145 ±  6%, n =  3, at 30  min) 
(Figure  3A). Then, dose–response analysis was performed in 
the absence and presence of treatment 30 min with camel milk 
that clearly showed that camel milk had no effect on the insulin 
dose–response in cells co-expressing hIR–Rluc8 and IRS1–YFP 
(Figure 3B). By contrast, camel milk significantly potentiated the 
maximal response (efficacy) of insulin in cells co-expressing hIR–
Rluc8 and Grb2–Venus (Emax = 142.6 ± 10.4%, n = 6, at 10 μM 
of insulin) (Figure 3C). Notice that no effect on insulin potency 
was observed, suggesting no effects on the binding properties of 
insulin receptor (Figure 3C). However, the fact that camel milk 
potentiated BRET signals at saturating concentrations of insulin 
further suggests an allosteric action, which seems to specifically 
impact hIR–Grb2 but not hIR–IRS1 association, conformation, 
and/or activation.
The Peptide/Protein nature of the 
Potentiating agent of camel Milk
To further characterize the potentiating effect of camel milk 
on insulin and its receptor, we performed various camel milk 
fractionations and tested their putative effects on BRET signals 
between hIR–Rluc8 and Grb2–Venus (Figure 4). First, we simply 
separated the whole milk into two major fractions, caseins that 
represent the major proteins (~80%) of the mammalian milk 
and whey containing the rest of milk proteins as illustrated by 
SDS-PAGE followed by Coomassie blue staining (Figure 4A). As 
shown in Figure 5A, while the whole defatted camel milk nicely 
potentiated insulin-induced BRET increase neither casein nor 
whey fractions (1  mg/ml) affected the insulin-induced BRET 
signals. The whey fraction had even a negative effect on the BRET 
signals (Figure 5A) probably due to the low pH (~5) of the frac-
tion (data not shown). These data indicate that caseins cannot 
be involved and/or this method of fractionation did not allow 
preserving the biological activity of the camel milk.
Next, we separated the protein and non-protein fractions 
of camel milk using gel filtration chromatography through 
Sephadex G-25 column (Figure 4B). Protein quantification in the 
fractions that we randomly took revealed that significant proteins 
were collected in the fractions 25 (5 mg/ml), 30 (11.4 mg/ml), 
and to lower extent 45 (0.73 mg/ml). The presence of proteins 
in these fractions was also confirmed by SDS-PAGE followed 
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FigUre 1 | BreT assay to monitor hir activation. (a) Schematic representation of the BRET-based assay to monitor insulin-induced hIR activation through the 
detection of the physical proximity between hIR–Rluc8 and its YFP-tagged signaling proteins. For this, HEK293 cells transiently co-expressing hIR–Rluc8 with either 
IRS1–YFP (B,D) or Grb2–Venus (c,e) were stimulated (red circle) or not (black square) with 100 nM (B,c) or increasing doses (D,e) of insulin and BRET 
measurements were performed in real-time and live cells as described in Section “Materials and Methods.” Data are mean ± SEM of three to six independent 
experiments performed in triplicate.
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by Coomassie blue staining (Figure 4A). These fractions freshly 
obtained were then tested for their effects on the BRET signals 
between hIR–Rluc8 and Grb2–Venus by taking the fractions 13 
and 65 as non-protein ones. For this, cells were first pre-incubated 
30 min with the different fractions and BRET signals were meas-
ured upon cell stimulation with 100 nM of insulin. As shown in 
Figures 5B,C, the potentiation of insulin-induced BRET signals 
was observed with the fractions 25, 30, and to lower extent 45, but 
not with the non-protein fractions, 13 and 65. These observations 
strongly suggest the involvement of peptides/proteins of camel 
milk in the potentiation of insulin-induced hIR activation.
To further consolidate this conclusion, we carried out separa-
tion of camel milk proteins according to their molecular weight 
using Amicon Ultra-15 centrifugal filters by cutting off at 10, 30, 
and 50 kDa and then tested the filtered fractions for their effects 
in BRET assay as described above. As shown in Figure  5D, 
similarly to the whole defatted camel milk, all the separated frac-
tions significantly increased insulin-induced BRET signals. The 
difference in the effects may be due to the final proteins collected 
in each fraction after filtration (Figure 5D). Thus, these data fur-
ther support the peptide/protein nature of the potentiating agent 
contained in camel milk. Moreover, the fact that the potentiation 
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FigUre 2 | effect of camel milk on BreT between hir–rluc8 and its signaling proteins. HEK293 cells transiently co-expressing hIR–Rluc8 and either 
IRS1–YFP (a,c) or Grb2–Venus (B,D–F) were first pre-treated (blue triangle) or not (black square and red circle) 30 min with camel milk before BRET measurements 
were performed in the absence or presence of stimulation with 100 nM of insulin as indicated. In parallel, luminescence (e) and fluorescence (F) analysis were 
carried out to quantify the relative expression of hIR–Rluc8 and Grb2–Venus, respectively. In (c,D), insulin-induced BRET signals in cells not pre-treated with camel 
milk (red circle) were normalized to 100%. Data are mean ± SEM of 3–10 independent experiments performed in triplicate.
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of insulin response was observed even with the preparation 
resulted from 10 kDa cutoff suggests that the potentiating agent 
has a molecular weight lower than 10 kDa. It is noteworthy to 
mention that all the effects were observed only with the freshly 
collected milk and separated fractions since such analysis using 
camel milk stored for more than a week did not show any effect of 
the whole milk or its fractions (data not shown). Together these 
data confirm the peptide/protein nature of the agent behind the 
biological activity of camel milk characterized by the potentiation 
of insulin-promoted hIR activation.
The effect of camel Milk on hir 
Downstream signaling Pathways
To further investigate the effects of camel milk on hIR activa-
tion, we attempted to link our BRET data with the downstream 
signaling pathways mediated by insulin and its receptor. For this, 
we investigated ERK1/2 and Akt phosphorylation in HEK293 
transiently expressing hIR–Rluc8 and Grb2–Venus using two 
approaches, an HTRF®-based assay in 384-well plate format as 
previously shown (32) and the classical SDS-PAGE followed by 
western blot. First, we performed a time-course analysis using 
HTRF®-based assay to determine the incubation time leading to 
the maximal ERK1/2 and Akt activation using the same cell sam-
ples. As a result, insulin nicely induced ERK1/2 phosphorylation 
with a transient kinetics and a maximum at 5 min of stimulation 
(Figure  6A). In addition, Akt phosphorylation occurred after 
5 min of insulin stimulation but with a sustained response even 
after 30 min (Figure 6B). Therefore, we performed the follow-
ing HTRF experiments at 5 min of stimulation with insulin that 
showed strong increase in the HTRF signals reflecting ERK1/2 
(Figure  6C) and Akt (Figure  6D) phosphorylation mediated 
by hIR as previously shown for other receptors using similar 
HTRF®-based assay (32). Of course, these results are consist-
ent with the BRET data showing strong insulin-induced BRET 
increase between hIR–Rluc8 and IRS1–YFP and Grb2–Venus 
(Figures 1 and 2) since it is well known that ERK1/2 and Akt 
activation through hIR specifically engages Grb2/Ras and IRS1/
PI3-kinase pathways, respectively (29, 30).
Interestingly, we observed that treatment of cells 30 min with 
camel milk significantly increased the basal level of ERK1/2 phos-
phorylation and such effect was additive to the insulin-mediated 
response (Figure  6C). By contrast, neither the basal nor the 
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insulin-promoted Akt phosphorylation was significantly affected 
by camel milk treatment (Figure 6D). To further investigate this 
aspect, we also examined ERK1/2 phosphorylation by SDS-PAGE 
followed by western blot using the specific anti-phospho-ERK1/2 
antibody and stimulation with insulin at two saturating concen-
trations (100 nM and 1 μM). As shown in Figure 6E, camel milk 
treatment significantly increased the basal phospho-ERK1/2 
and very largely potentiated insulin-dependent response with 
stronger potentiation at 1 μM of insulin as illustrated by the quan-
tification of duplicated experiments (Figure 6F). By contrast, the 
phosphorylation of Akt assessed in parallel to ERK1/2 showed 
no significant effect of camel milk (data not shown). Together 
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these observations are consistent with the HTRF data shown in 
Figures 6C,D using 100 nM of insulin. Interestingly, at 1 μM of 
insulin the cells pre-treated with camel milk showed a response 
being more than additive (sixfolds increase) compared to the sum 
of responses from untreated cells (twofolds) and milk-treated 
cells without insulin stimulation (twofolds) (Figure  6F). Even 
though, this observation does not clarify if camel milk induced 
ERK1/2 phosphorylation via hIR, this supports the existence 
of an allosteric effect of camel milk on insulin and its receptor 
with respect to ERK1/2 phosphorylation, which may depend on 
the allosteric potentiation of hIR–Grb2 association/activation 
observed in Figures 2 and 3.
DiscUssiOn
As stated above, many previous studies in  vivo using type 
1- diabetic rat models reported hypoglycemic properties of camel 
milk (11–19, 35). Because of the pivotal role of insulin receptor 
and its intracellular signaling pathways in the control of glucose 
uptake and its blood levels, we hypothesized that the hypoglyce-
mic effects of camel milk may involve an action of its components 
directly on insulin receptor in insulin-dependent or -independ-
ent ways. To address this question, we examined the effect of 
camel milk and its fractions on the activation of hIR in HEK293 
cells. For this, we used BRET technology based on the assessment 
of the physical binding of the two major key signaling proteins, 
IRS1 and Grb2, to hIR upon insulin stimulation as previously 
shown for hIR (23, 24) and EGFR (for Grb2) (25). Moreover, we 
attempted to link the BRET data with the downstream signal-
ing of hIR through the study of the impact of camel milk on the 
two major hIR signaling pathways, including ERK1/2 and Akt 
phosphorylation in HEK293 cells.
Both real-time kinetics and dose–response BRET analysis 
clearly showed significant and specific recruitment of IRS1 and 
Grb2 proteins to the activated hIR with the expected potency of 
insulin (23, 29, 34). In addition, the BRET data showing strong 
insulin-induced BRET increase between hIR–Rluc8 and IRS1–
YFP and Grb2–Venus (Figures  1 and 2) were also supported 
by the data demonstrating ERK1/2 and Akt phosphorylation 
via hIR activation in HEK293 cells (Figure  6). Together, these 
observations are in accordance with the classical paradigm 
of hIR signaling since it is well known that ERK1/2 activation 
engages Grb2/Ras pathway, while Akt activation results from the 
engagement of IRS1/PI3-kinase pathway (29, 30). Thus, our data 
validate the BRET assay by demonstrating that insulin-promoted 
BRET increases between hIR and IRS1 and Grb2 likely reflects 
the activation of hIR.
Next, we examined the effect of camel milk and its fractions 
on BRET signals between hIR–Rluc8 and either IRS1–YFP or 
Grb2–Venus. Indeed, in a direct treatment of cells with fresh 
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camel milk alone, our data showed that camel milk did not 
promote any significant BRET increase between hIR–Rluc8 and 
IRS1–YFP or Grb2–Venus, suggesting that camel milk itself did 
not activate hIR in our model. It is worth noting that BRET is a 
proximity-based assay where the distance and the orientation of 
the donor (Rluc8) and the acceptor (YFP or Venus) are critical to 
make possible and efficient enough the energy transfer between 
Rluc8 and YFP/Venus within protein complexes. Accordingly, 
the absence of BRET increase between hIR–Rluc8 and IRS1–YFP 
and Grb2–Venus may have two different explanations. The first 
explanation implies the absence of hIR activation by camel milk 
and thereby no IRS1 and Grb2 recruitment is promoted. If such 
scenario happened, then our BRET data suggest the absence of 
any sufficient insulin in camel milk and/or “insulin-like” activity. 
The second possibility is that camel milk could to some extent 
activate hIR but the conformation of the activated hIR–Rluc8 
was not translated into BRET changes with IRS1–YFP and 
Grb2–Venus. This means that the two proteins could bind to hIR 
but their relative amount is still weak and/or their distance and/
or orientation are unfavorable within the activated complex to 
trigger sufficient BRET increase. Interestingly, in ERK1/2 phos-
phorylation assay, camel milk significantly induced ERK1/2 but 
not Akt phosphorylation even in the absence of insulin stimula-
tion (Figures 6C,E), suggesting selective activation of ERK1/2 
but not Akt pathway in HEK293 cells. Of course, such an effect 
could not be necessarily specific to hIR activation induced by 
camel milk since no evidence for camel milk binding directly 
to hIR. Thus, our data cannot rule out the possibility that camel 
milk activates other membrane receptors in HEK293 cells to 
induce ERK1/2 phosphorylation. Taken together with the BRET 
data, this point is still not clear and further investigations are 
required.
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The other important finding of our study is doubtlessly the 
effects of camel milk and the pharmacological profiling of its 
fractions on insulin-induced hIR activation. Our study consti-
tutes the first demonstration of a direct effect of camel milk on 
hIR activation at the cellular level. Indeed, we observed that 
camel milk and some of its fractions intriguingly potentiated 
the efficacy but not the potency of insulin to promote BRET 
increase. Interestingly, this was specific to BRET between 
hIR–Rluc8 and Grb2–Venus, but not IRS1–YFP. Indeed, 
kinetics (Figure 2D) and dose–response (Figure 3C) analysis 
clearly demonstrated that camel milk selectively potentiated 
the BRET signal between hIR–Rluc8 and Grb2–Venus even 
at the maximal levels and the saturating concentrations of 
insulin (100  nM–10 μM). It is worth noting that camel milk 
did not affect insulin potency, suggesting no effect on the bind-
ing properties of insulin. This scenario is characteristic of an 
allosteric interaction between a camel milk component and 
insulin at the level of hIR, which specifically impacts hIR–Grb2 
but not hIR–IRS1 association and/or conformation as well as 
the activation of the complex. Indeed, under our conditions, the 
activation level of hIR by insulin tends to saturation as shown in 
the dose curves. Subsequently, any further increase in the BRET 
signals cannot be explained by further recruitment of Grb2 to 
the activated receptor. The other argument for allosteric effects 
of camel milk is the absence of desensitization of hIR follow-
ing 30  min of treatment with camel milk where insulin fully 
activated hIR and even a potentiation was observed. An orthos-
teric binding of camel milk would have been characterized by 
either no further activation by insulin due to the saturation of 
the system and/or desensitization of hIR or even an inhibition 
(in case of antagonistic action). One way to reconcile all this 
is to hypothesize that camel milk allosterically induces and 
stabilizes specific conformation of hIR, which may be different 
to both inactive (basal condition) and active (insulin bound) 
hIR (Figure 7). Such a conformation appears to be unfavorable 
with regard to BRET process between hIR–Rluc8 and IRS1–YFP 
and Grb2–Venus in the absence of stimulation with insulin. 
Therefore, orthosteric binding of insulin activates hIR by induc-
ing further conformational changes within the receptor leading 
to favorable distance/orientation of both hIR–Rluc8 and Grb2–
Venus (but not IRS1–YFP) and thereby causing BRET increase. 
Accordingly, if camel milk really induced ERK1/2 activation 
via hIR, this would support the existence of camel milk-specific 
conformation of hIR, which is able to engage Grb2 to the recep-
tor and still sensitive to insulin stimulation even at the saturat-
ing concentrations through an allosteric activation mechanism. 
Of course, based on our data, the question whether camel milk 
induced ERK1/2 phosphorylation through its allosteric action 
on hIR is still unsolved. However, in camel milk-treated cells the 
insulin-mediated ERK1/2 phosphorylation was significantly 
potentiated in both HTRF®-based and western blot assays. 
Notice that the HTRF data only showed additive effects of camel 
milk on insulin-dependent ERK1/2 phosphorylation, indicat-
ing no direct association between hIR-dependent and  -inde-
pendent responses of the camel milk. By contrast, the western 
blot clearly demonstrated a strong potentiation of ERK1/2 
phosphorylation that was more than additive in cells co-treated 
with camel milk and insulin (Figures 6E,F). This observation 
supports the existence of an allosteric effect of camel milk on 
ERK1/2 phosphorylation, which may depend on the allosteric 
potentiation of the conformation of hIR–Grb2 complexes as 
shown in Figures 2 and 3. Such allosteric modulation on insulin 
receptor has been recently reported when selective antibodies 
were used in combination with insulin stimulation arguing 
for the existence of functional allosteric binding sites on hIR 
(36, 37). Regarding the interaction of hIR with IRS1 and Akt 
phosphorylation, camel milk affected neither the BRET signal 
between hIR–Rluc and IRS1–YFP nor Akt activation, both the 
basal and insulin-mediated response. These observations sug-
gest selective allosteric modulation of hIR by camel milk leading 
to changes in hIR–Grb2 interaction/conformation and ERK1/2 
but not IRS1/Akt pathways. This is consistent with the concept 
of functional selectivity, also referred as biased signaling, which 
consists of a given hormone or agent activating one specific 
subset of receptor signaling without affecting others. Similar 
properties were reported on insulin-like growth factor-1 with 
respect to ERK1/2 relative to Akt pathways (38). Moreover, the 
concept of biased signaling is now well documented for other 
membrane receptors, such as GPCRs (39, 40).
Furthermore, the data on BRET between hIR–Rluc8 and 
Grb2–Venus using the whole camel milk were also supported 
by those with the fractionated milk where the defatted milk was 
submitted to different separation protocols. Together, the frac-
tionation data converged to suggest that the potentiating agent 
contained in camel milk has a peptide/protein nature with a posi-
tive effect also observed in the fraction <10 kDa. Our data may 
be consistent with the previous studies showing that the amino 
acid sequences of some of the camel’s milk proteins are rich in 
half-cystine similarly to peptides belonging to insulin family (20). 
Of course, this crucial aspect needs further experimental and 
technical analysis and improvement in the aim to obtain optimal 
fractionation and identify the real potentiating agent. Also, we 
observed that the stability and storage condition of camel milk 
are two important elements determining the functionality of 
camel milk as previously shown for camel milk insulin (4). The 
activity of camel milk or its resulted fractions was significantly 
decreased or totally abolished when camel milk was used after 
its long storage further demonstrating the biological activity of 
camel milk components (data not shown). Together, our data are 
of great importance in the context of chemical and biochemical 
profiles of camel milk compared to other related milks, such 
as bovine or goat (5, 41–43). Indeed, the question regarding 
insulin content of camel milk is still unclear since some studies 
reported that camel milk contains high levels of insulin (2, 44), 
while others showed low insulin levels but significantly higher in 
camel colostrum (45). Moreover, insulin concentrations in camel 
milk have been reported to significantly depend on the lactation 
stages (3) as well as temperature and storage conditions (4, 46). 
These different observations must be considered when interpret-
ing the studies reporting the hypoglycemic effects of camel milk 
in vivo using both animal and human models of type 1 diabetes 
(11–19, 35). In fact, it still not clear how to explain the beneficial 
effects of camel milk and its plausible content of insulin since the 
hormone should be degraded in the stomach and if not it has to 
FigUre 7 | schematic model of allosteric action of camel milk on hir. The positive allosteric action of camel milk implies induction/stabilization of specific 
conformation of hIR with an impact on its downstream signaling. Indeed, in the presence of camel milk the conformation of hIR (conformation B) (B) is more efficient 
with regard to insulin-promoted ERK1/2 activation, but probably not Akt, compared to the conformation bound to insulin in the absence of camel milk component 
(conformation A) (a).
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remain functionally intact during the absorption process in the 
intestine (22, 45).
From the pathophysiological point of view, our findings in 
transfected HEK293 cells using BRET technology help to better 
understand the previous studies on the hypoglycemic proper-
ties of camel milk in both animal and human models (11–19, 
35). Indeed, our data bring for the first time the evidence for 
camel milk acting allosterically at the level of insulin receptor 
that appears to differentially impact its downstream signaling 
(Figure 7). Nevertheless, the link between the effects of camel 
milk that we reported here and its hypoglycemic properties 
is still weak since our data reported potential effects on the 
mitogen-activated protein kinase (MAPkinase) involved in 
proliferation and differentiation processes of hIR (29, 30). By 
contrast, no significant effects were observed on hIR–IRS1 
association and Akt phosphorylation constituting the metabolic 
pathway involved the transport of glucose and glycolysis (29, 
30). Therefore, further investigations are required to confirm 
our data in other models and to better dissect such effects of 
camel milk components at the molecular level in order to make 
a link with putative effects on glucose uptake in insulin-sensitive 
tissues. Also, the big challenge would be the identification and 
characterization of the active agent contained in camel milk and 
investigating its effects on insulin binding and hIR activation. 
The implication of adiponectins and other hormones contained 
in milk and reported to influence hIR activity and signaling could 
be the interesting tracks to investigate (47–49). Finally, it would 
be interesting to extend the study to other receptors involved in 
the glucose homeostasis.
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